Phase II evaluation of the tyrosine kinase inhibitor MLN518 in patients with acute myeloid leukemia (AML) bearing a FLT3 internal tandem duplication (ITD) mutation Meeting Abstract
| Authors: | De Angelo, D. J.; Stone, R. M.; Heaney, M. L.; Nimer, S. D.; Paquette, R.; Bruner-Klisovic, R.; Caligiuri, M. A.; Cooper, M. R.; Le-Cerf, J. M.; Iyer, G. |
| Abstract Title: | Phase II evaluation of the tyrosine kinase inhibitor MLN518 in patients with acute myeloid leukemia (AML) bearing a FLT3 internal tandem duplication (ITD) mutation |
| Meeting Title: | 46th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 104 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2004 Dec 4-7 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2004-11-16 |
| Start Page: | 496A |
| End Page: | 497A |
| Language: | English |
| ACCESSION: | WOS:000225127501793 |
| PROVIDER: | wos |
| PUBMED: | 15562524 |
| DOI: | 10.1182/blood.V104.11.1792.1792 |
| Notes: | Meeting Abstract: 1792 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
